您的位置: 首页 > 农业专利 > 详情页

Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
专利权人:
Board of Regents, The University of Texas System
发明人:
Kamat Ashish M.,Briggman Joseph,Dinney Colin P.,Urbauer Diana
申请号:
US201314382374
公开号:
US9551713(B2)
申请日:
2013.03.04
申请国别(地区):
美国
年份:
2017
代理人:
Parker Highlander PLLC
摘要:
Methods for predicting cancer recurrence following a BCG immunotherapy are provided. In some aspects, cytokine levels from a patient are measured before and after a BCG therapy and the changes in cytokine levels are used to determine the risk of cancer lapse. Methods for selecting a patient for a further anti-cancer therapy are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充